The trajectory of companies tied to Viagra's legacy presents a complex investment scenario . While the initial boom generated substantial gains, generic copies have significantly eroded market share . Investing in connected pharmaceutical companies now requires a discerning assessment of proprietary rights , evolving patient trends , read more and